Reversal of albuminuria by combined AM6545 and perindopril therapy in experimental diabetic nephropathy

Volume: 175, Issue: 23, Pages: 4371 - 4385
Published: Nov 6, 2018
Abstract
Background and Purpose The endocannabinoid (EC) system has been implicated in the pathogenesis of diabetic nephropathy (DN). We investigated the effects of peripheral blockade of the cannabinoid CB 1 receptor as an add‐on treatment to ACE‐inhibition in type 1 diabetic mice (DM) with established albuminuria. Experimental Approach Renal functional parameters (albumin excretion rate, creatinine clearance), tubular injury, renal structure, both EC...
Paper Details
Title
Reversal of albuminuria by combined AM6545 and perindopril therapy in experimental diabetic nephropathy
Published Date
Nov 6, 2018
Volume
175
Issue
23
Pages
4371 - 4385
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.